CLVLF News Alert Clinuvel Pharm Ords (CLVLF) 2.2300 09/28/2014

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
Clinuvel Pharm Ords (CLVLF) 2.2300 $CLVLF

Retrophin plans to buy remaining shares in Clinuvel Pharmaceuticals in all cash offer
M2 - Mon Jul 28, 6:13AM CDT
Pharmaceutical company Retrophin (NasdaqGM:RTRX) on Sunday announced its proposal to acquire all of the remaining shares of Clinuvel Pharmaceuticals (ASX:CUV.AX).

Retrophin Proposes Acquisition of Clinuvel Pharmaceuticals
Business Wire - Sun Jul 27, 10:47PM CDT
Retrophin, Inc. (NASDAQ:RTRX) today announced that on July 17, 2014 it submitted a proposal to the Board of Directors of Clinuvel Pharmaceuticals Ltd (ASX:CUV) to acquire by scheme of arrangement all of the shares of Clinuvel stock that Retrophin does not own for (1) 0.175 Retrophin shares per Clinuvel share, or (2) A$2.17 per share in cash. Retrophin currently owns approximately 4.88% of Clinuvel shares.

Actinic Keratosis - Pipeline Review, H2 2012
M2 - Fri Aug 02, 6:35AM CDT
Research and Markets (http://www.researchandmarkets.com/research/s2gp3d/actinic_keratosis) has announced the addition of the "Actinic Keratosis - Pipeline Review, H2 2012" report to their offering. This research provides an overview of the indication's therapeutic pipeline. This report provides information on the therapeutic development for actinic keratosis, complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key players involved in the therapeutic development for actinic keratosis. The information is built using data and information sourced from proprietary databases, company/university websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources. Scope - A snapshot of the global therapeutic scenario for actinic keratosis. - A review of the actinic keratosis products under development by companies and universities/research institutes based on information derived from company and industry-specific sources. - Coverage of products based on various stages of development ranging from discovery till registration stages. - A feature on pipeline projects on the basis of monotherapy and combined therapeutics. - Coverage of the actinic keratosis pipeline on the basis of route of administration and molecule type. - Key discontinued pipeline projects. - Latest news and deals relating to the products. Reasons to buy - Identify and understand important and diverse types of therapeutics under development for actinic keratosis. - Identify emerging players with potentially strong product portfolio and design effective counter-strategies to gain competitive advantage. - Plan mergers and acquisitions effectively by identifying players of the most promising pipeline. - Devise corrective measures for pipeline projects by understanding actinic keratosis pipeline depth and focus of Indication therapeutics. Key Topics Covered: List of Tables List of Figures Introduction Report Coverage Actinic Keratosis Overview Therapeutics Development An Overview of Pipeline Products for Actinic Keratosis Companies Involved in Actinic Keratosis Therapeutics Development Actinic Keratosis - Therapeutics Assessment Drug Profiles Featured News & Press Releases Appendix Companies Mentioned: - Almirall, S.A - Birken GmbH - Celtic Pharmaceutical Holdings L.P - Clinuvel Pharmaceuticals Limited - FunZyme BioTechnologies S.A - GliaMed, Inc - Meda AB - MediQuest Therapeutics, Inc - Moberg Derma AB - NexMed, Inc - Quest PharmaTech Inc - Telormedix SA For more information visit http://www.researchandmarkets.com/research/s2..._keratosis

Vitiligo - Pipeline Review, H1 2013
M2 - Mon Jun 17, 6:31AM CDT
Research and Markets (http://www.researchandmarkets.com/research/w6wkh6/vitiligo) has announced the addition of the "Vitiligo - Pipeline Review, H1 2013" report to their offering. "Vitiligo - Pipeline Review, H2 2013", provides an overview of the indication's therapeutic pipeline. This report provides information on the therapeutic development for Vitiligo, complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key players involved in the therapeutic development for Vitiligo. Scope - A snapshot of the global therapeutic scenario for Vitiligo. - A review of the Vitiligo products under development by companies and universities/research institutes based on information derived from company and industry-specific sources. - Coverage of products based on various stages of development ranging from discovery till registration stages. - A feature on pipeline projects on the basis of monotherapy and combined therapeutics. - Coverage of the Vitiligo pipeline on th

SurModics Signs License Agreement with Clinuvel Pharmaceuticals
M2 - Sun Jun 16, 7:09AM CDT
SurModics, Inc. (Nasdaq: SRDX), a leading provider of drug delivery and surface modification technologies to the healthcare industry, announced today that it has entered into a license agreement with Clinuvel Pharmaceuticals Limited of Melbourne, Australia. Under the agreement, the Company's SurModics Pharmaceuticals unit has licensed certain of its biodegradable polymer implant technology to Clinuvel for the treatment of sun-induced skin disorders. Terms of the agreement were not disclosed.




Scroll down for more posts ▼

Top 10 Most Recent News Articles

ZKONG, Hagebau Push ESLs in European Retail Revamp

Updated Category News Views 156

ESLs: The Next Step in Retail Revamp Here’s the scoop: ZKONG and hagebau are making waves in the retail scene over in Germany. They’re bringing in Electronic Shelf Labels (ESLs) to kick traditional price tags to the curb. What started as a shake-up in supermarkets now rolls into the world of home improvement retail—headline by hagebaumarkt in Selb after nearly half...

Continue Reading
ChinaMarket: Linyi's Gateway for Global Buying Delegations

Updated Category News Views 64

Unlocking Trade Potential in Linyi, China Linyi, in Shandong province, has flipped the switch on the sourcing circuit with one powerful invite to global buying delegations. As we sit perched on the fence of an economically tangled world, China's open arms to Southeast and Central Asian buyers mark a significant shift towards more fluid trade connections. The Fourth Linyi...

Continue Reading
Texas Home Boasts PGA-Caliber Green with Synthetic Turf

Updated Category News Views 13

Swinging for Luxury in Your Backyard Who'd have thought that a chunk of Austin, Texas, could boast a putting green that’s giving any PGA course a run for its money? We’re talking about a family here who decided they’d had enough of scalding summers and winter chills and wanted a taste of that country club glam at home without the upkeep headaches. The Rise of...

Continue Reading
TCL CSOT Displays Shine in TIME’s 2026 Inventions

Updated Category News Views 10

Breaking Boundaries with Display Technology Ah, the tech game—if you're not moving forward, you're slipping into obscurity. TCL must be grinning ear to ear as its displays just snagged a coveted spot on TIME's Best Inventions of 2026 list. We're talking about the TCL X11L SQD-Mini LED TV, the XTEINK X4 Pro Pocket eReader, and the Framework Laptop 13 Pro. Yep, all...

Continue Reading
Shareholder Stakes at Risk in Major Mergers

Updated Category News Views 52

Deals in the Spotlight: What's at Stake? Ever wonder if you're getting the short end of the stick while company insiders walk away with the spoils? That's the song and dance investors face with the likes of ADT Inc., Instacart, and MidCap Financial Investment Corporation lately. If you're wearing the shareholder hat, you might want to tune into the noise around these...

Continue Reading
BingX's AI Enjoys Roaring Adoption in Trading

Updated Category News Views 70

Traders and their AI tools—sounds like a match made in market heaven, right? That's the buzz coming out of BingX, the multi-asset trading platform that's been shaking things up in the fintech realm. These days, it seems like everyone's hitching a ride on the AI train. Explosive Growth in AI Utilization Now, let's talk numbers, and boy, are these numbers juicy. Daily...

Continue Reading
Aries Unveils Prediction Markets Amid Midterm Fervor

Updated Category News Views 103

Aries Enters Prediction Markets Ah, Aries is diving into the world of prediction markets, riding the wave of excitement around the 2026 U.S. midterm elections. They're tossing their hat in the ring with Aries Mobile, letting eligible customers toy with event contracts on not just political outcomes, but economic data and financial market trends too. With ForecastEx LLC,...

Continue Reading
Twilio's SEC Investigation: Legal Impacts on Investors

Updated Category News Views 38

Twilio's Legal Troubles: Investors Take Notice Twilio's facing a firestorm, folks. After guiding its organic revenue growth down a few notches, the company saw its shares plummet 17%. Now, they're under the microscope for possibly not playing it straight with their growth numbers, and that’s never a good look with Uncle Sam watching. Folks at Levi & Korsinsky are on the...

Continue Reading
KSAT and MSU Boost Lunar Network for Space Growth

Updated Category News Views 66

Breaking Ground in Space: KSAT and MSU Join Forces Here's a cosmic twist in the world of satellite communications: KSAT and Morehead State University (MSU) are teaming up to expand the lunar frontier. This ain't small potatoes; it's a strategic handshake aimed at beefing up KSAT's lunar network. They're set to amplify support for the growing hunger in deep space...

Continue Reading
Beta Bionics Faces Class Action Deadline Amid Controversy

Updated Category News Views 16

Beta Bionics' Investors in a Bind: Lead Plaintiff Opportunity Looms Alright, folks, it’s time to size up the situation at Beta Bionics, Inc. (NASDAQ: BBNX). If you're holding onto their stock and nursing some serious losses, you're not alone. The clock's ticking on the November 3, 2026 deadline to step up and lead the charge in a class action lawsuit. What's the Fuss...

Continue Reading

Top 5 Most Recently Viewed Articles

Pharmaceutical Analytical Testing: Growth and Innovations Ahead

Updated Category News Views 156

Overview of the Pharmaceutical Analytical Testing Market The pharmaceutical analytical testing market is undergoing remarkable growth, fueled by the increasing complexity in medication development and an insatiable demand for biologics and biosimilars. This sector requires advanced testing to ensure new therapeutics meet safety and efficacy standards while adhering to...

Continue Reading
Navigating Market Challenges: A Fresh Look at Nasdaq's Future

Updated Category News Views 155

Nasdaq's Business Evolution Nasdaq, Inc. (NASDAQ:NDAQ) stands as a prominent global financial services entity that continually adapts to a dynamic marketplace filled with shifting trading volumes and strategic acquisitions. Recently, the company has made noteworthy strides in enhancing its business model and expanding its market influence. Investors and analysts are...

Continue Reading
Exploring the Future of Automotive Active Seat Headrests

Updated Category News Views 178

Understanding the Automotive Active Seat Headrests Market Growth The automotive active seat headrests market is set to expand significantly, with projections suggesting a valuation reaching USD 25.49 billion by 2031. This growth is largely attributed to the increasing consumer focus on vehicle safety and the rising integration of safety technologies in modern automobiles....

Continue Reading
Crown Castle Boosts Investor Confidence with Dividend Increase

Updated Category News Views 184

Crown Castle Announces Enhanced Quarterly Dividend Crown Castle Inc. (NYSE: CCI), a leading provider of shared communications infrastructure, has shared exciting news for its investors. The Board of Directors has declared a quarterly cash dividend amounting to $1.565 per share. This dividend is a testament to Crown Castle's solid financial health and commitment to...

Continue Reading
Diginex's Strategic Acquisition: Enhancing Human Rights Solutions

Updated Category News Views 156

Diginex's Commitment to Enhancing Human Rights in Supply Chains Diginex Limited (NASDAQ: DGNX), a leader in Sustainability RegTech solutions, has made significant strides by announcing a memorandum of understanding to acquire The Remedy Project Limited. This strategic move highlights Diginex's focused effort to strengthen its advisory capabilities regarding human rights...

Continue Reading